🇰🇷 Relafen in South Korea

Relafen (NABUMETONE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Relafen in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in South Korea

Frequently asked questions

Is Relafen approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Relafen in South Korea?

Marketing authorisation holder not available in our data.